EU proposal would send rejected migrants to centres outside the bloc for deportation
The European Commission on Tuesday proposed that member countries be allowed to set up centres in non-EU countries where ...
JD Supra16h
State Court Rejection of Federal Preemption in Product Liability Claim Highlights Uncertainty for Manufacturers
On Feb. 11, 2025, the Missouri Court of Appeals for the Eastern District in Durnell v. Monsanto Co., upheld a jury verdict awarding $1.25 million ...
The Manila Times21h
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of kidney transplant loss, with approximately ...
Schneider National: Buying Opportunities Despite Technical Risks
Schneider National, Inc. remains a resilient company with stable margins, driven by its prudent pricing, expansion, and ...